Treating lung scarring by focusing on each person's problems
Part of Lungs & breathing clinical trials.
This study looks at how to better treat different types of lung scarring (fibrotic ILD) by focusing on each person's specific problems. It is for adults who are already being treated for a fibrotic ILD at one of two hospitals in Perth, Australia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have a type of lung scarring called fibrotic interstitial lung disease (ILD).
- Your diagnosis must be confirmed by a team of specialists at a hospital Lung Clinic.
- You must be on a stable dose of your ILD treatment for at least 1 month before joining.
- You cannot have had a sudden flare-up of your symptoms in the past 4 weeks.
- You cannot have serious mental health issues (like active suicidal thoughts or severe depression) that need more intensive care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with chronic lung scarring (fibrosing interstitial lung disease) who are in the intensive care unit for severe breathing failure. It aims to better understand their condition and care, which may help improve future treatments.
This study looks at how to find and treat fibrotic interstitial lung disease (a condition where lung tissue becomes scarred and stiff) as early as possible. It may help people with this type of lung disease get better care.
This trial tests whether starting anti-scarring medication early helps people with a type of lung scarring called fibrotic interstitial lung disease (ILD) that hasn't gotten worse. The goal is to see if it can prevent further damage and improve breathing.
This study is for people with a specific type of lung scarring (not IPF) to understand how the disease progresses. Researchers will collect detailed health information, imaging, and blood samples to learn more about the condition.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study tests a home-based exercise and health coaching program for people with scarring in their lungs (fibrotic ILD). The goal is to see if doing rehab at home, with support from a coach, can help you feel better and breathe easier.
Hear when a new Interstitial Lung Diseases (ILD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.